Turn Therapeutics Inc.
Price Action
Technical Summary
EMERGING TRENDTurn Therapeutics Inc. is attempting to emerge into an uptrend but lacks full moving average alignment. Relative strength is leading (RS Rating: 96), indicating clear outperformance against the broad market. However, price is extended 83% above the 50-day line, increasing the risk of a mean reversion.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $6.48 | +49.86% | ABOVE |
| 50 SMA | $5.31 | +83.02% | ABOVE |
| 100 SMA | $4.37 | +121.99% | ABOVE |
| 150 SMA | $4.23 | +129.59% | ABOVE |
| 200 SMA | $— | — |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is TTRX in an uptrend right now?
TTRX has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.
Is TTRX overbought or oversold?
TTRX's RSI (14) is 71. The stock is in overbought territory (RSI > 70), which may signal a pullback.
Is TTRX outperforming the market?
TTRX has a Relative Strength (RS) Rating of 96 out of 99. Yes, TTRX is a market leader, outperforming 96% of all stocks over the past 12 months.
Where is TTRX in its 52-week range?
TTRX is trading at $9.71, which is 37% of its 52-week high ($26.50) and 30% above its 52-week low ($2.57).
How volatile is TTRX?
TTRX has a Beta of 1.52 and 52-week volatility of 111%. It's more volatile than the S&P 500 - expect bigger swings.